HealthDay - MONDAY, Oct. 10 (HealthDay News) -- An experimental Alzheimer's
disease drug, gantenerumab, may help lower levels of amyloid plaque in the
brains of people with the disease, an early clinical trial indicates.
You are here:
Health 
Diseases & Conditions New Alzheimer's Drug Shows Early Promise
(HealthDay)
Diseases & Conditions New Alzheimer's Drug Shows Early Promise
(HealthDay)
